 |
Nature Born, Doctor Formulated, Patient Proven. |
 |
|
Parnell to reassume sales, marketing & distribution of
MouthKote® Oral Moisturizer
February 16, 1998 -- Parnell Pharmaceuticals has announced that
effective March 1, 1998, it will reassume the sales, marketing &
distribution of its MouthKote® oral
moisturizer.
MouthKote was previously marketed for the last three years under a
distribution agreement by Scandipharm, Inc. of Birmingham, Alabama.
MouthKote®
was developed for the treatment of xerostomia (dry mouth) caused by
disease such as cancer or medical therapy. The most severe cases of
xerostomia are caused from radiation therapy and surgery to the head and
neck. Other causes of xerostomia result from autoimmune diseases such as
Sjögren's Syndrome, HIV/AIDS, lupus, and the aging process. However, the
leading cause of xerostomia results from the effects of drug therapy,
including the use of some analgesics, antihypertensives, decongestants,
antihistamines and chemotherapy. In a double-blind, clinical study at the
University of Minnesota Dental Clinic, MouthKote was preferred by over 80%
of the patients, and it gave the patients relief from dry mouth for more
than three times longer than the other products compared. MouthKote®
is available through retail pharmacies in eight-ounce and two-ounce
bottles.
For More
Information Contact:
Parnell
Pharmaceuticals, Inc.
Post Office Box 5130; Larkspur, CA 94977 USA
#
#
#
|


 |
|
 |
You may duplicate this info box. Click in here,
go to Table > Select > Table, then Edit > Copy and Edit > Paste.
The box will automatically resize to fit the space that it is
in.
|
 |
|
 |
You may duplicate this info box.
|
|